International Classification of Retinopathy of Prematurity, Third Edition

Chiang M. F., Quinn G. E., Fielder A. R., Ostmo S. R., Chan R. V. P., Berrocal A., ...Daha Fazla

OPHTHALMOLOGY, cilt.128, sa.10, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 128 Sayı: 10
  • Basım Tarihi: 2021
  • Doi Numarası: 10.1016/j.ophtha.2021.05.031
  • Dergi Adı: OPHTHALMOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, MEDLINE
  • Anahtar Kelimeler: Neonatology, Pediatric ophthalmology, Prematurity, Retina, Retinopathy of prematurity, FOVEAL AVASCULAR ZONE, PLUS DISEASE, LASER TREATMENT, INTRAVITREAL BEVACIZUMAB, INTEREXPERT AGREEMENT, DIAGNOSIS, EFFICACY, PRETERM, INFANTS, HISTORY
  • Gazi Üniversitesi Adresli: Evet

Özet

Purpose: The International Classification of Retinopathy of Prematurity is a consensus statement that creates a standard nomenclature for classification of retinopathy of prematurity (ROP). It was initially published in 1984, expanded in 1987, and revisited in 2005. This article presents a third revision, the International Classification of Retinopathy of Prematurity, Third Edition (ICROP3), which is now required because of challenges such as: (1) concerns about subjectivity in critical elements of disease classification; (2) innovations in ophthalmic imaging; (3) novel pharmacologic therapies (e.g., antievascular endothelial growth factor agents) with unique regression and reactivation features after treatment compared with ablative therapies; and (4) recognition that patterns of ROP in some regions of the world do not fit neatly into the current classification system.